AI-generated summary
The authors randomized 30 breast cancer survivors to 14 days of daily bright blue-green light or dim red light, timed by chronotype. No between-group differences were found, but within-group improvements in sleep disturbance, fatigue and depressive mood were reported over time. The authors describe the findings as only limited evidence, and the dim red light group also improved unexpectedly.
- Participants
- 30
- Who or what was studied
- Post-treatment breast cancer survivors, 1-3 years after chemotherapy and/or radiation, mean age 52.5 years
- Limits stated in the abstract
- The authors state the sample was small (30 women), the between-group differences were not significant, and the unexpected improvements in the dim red light control group remain unexplained.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on researchsquare.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Lux, Randomized controlled trial, Bright light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.